Central Virginia

Filter by Region, Sector, or Focus
The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-generation technology to identify potential security threats and protect Americans. UVA won the contract through a competitive…
The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-generation technology to identify potential security threats and protect Americans. UVA won the contract through a competitive…
The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.
AgroSpheres, developed through Darden's iLab Incubator, highlights how the University's entrepreneurial ecosystem fosters ventures that make a real-world impact.
AgroSpheres, developed through Darden's iLab Incubator, highlights how the University's entrepreneurial ecosystem fosters ventures that make a real-world impact.
The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.
Much of the industry's success wouldn't be possible without the talent that comes out of UVA, which has developed various ways to support researchers.
CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork, a UVA Discovery Park.
Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.
One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth, bringing with them hundreds of jobs directly and…
The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.
Melissa M. Lubin will lead UVA's School of Continuing and Professional Studies (SCPS) as Dean with emphasis on programs that respond to both student and workforce demand.